Effects of Massage Therapy on Peripheral Neuropathy and Quality of Life - Trial NCT05433246
Access comprehensive clinical trial information for NCT05433246 through Pure Global AI's free database. This phase not specified trial is sponsored by Fatma Arikan and is currently Completed. The study focuses on Chemotherapy-induced Peripheral Neuropathy. Target enrollment is 52 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Fatma Arikan
Akdeniz University
Timeline & Enrollment
N/A
Feb 01, 2012
May 01, 2013
Primary Outcome
Peripheral Neuropathy Evaluation Form,Self-Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale (S-LANSS),MD Anderson Symptom Inventory,European Organisation for Research and Treatment of Cancer-Quality of Life Scale,American National Cancer Institute Cancer Therapy Evaluation Program Common Toxicity Criteria, Version 2.0
Summary
The aim of this randomized controlled experimental study was to determine the effect of
 massage applied to colorectal cancer patients receiving chemotherapy on peripheral neuropathy
 and quality of life.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05433246
Non-Device Trial